Skip to main content
Top

Nutritional Risk Factors in the Pathogenesis of Parenteral Nutrition-Associated Liver Disease

  • 01-09-2017
  • Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)
Published in:

Abstract

Purpose of Review

Parenteral nutrition has been a lifesaving therapy for individuals who cannot sustain adequate oral or enteral nutrient intake to maintain fluid, electrolyte, and nutrient balance. Nonetheless, parenteral nutrition can lead to an increased risk of complications, such as parenteral nutrition-associated liver disease (PNALD). The pathogenesis of PNALD has been associated with multiple risk factors, such as longer duration, reduced small bowel length, decreased enteral intake, and bacterial infections. Nutritional risk factors also play an important role in the development of PNALD. This review presents several nutrient deficiencies and excesses that have been associated with PNALD.

Recent Findings

Deficiencies in certain nutrients (amino acids, essential fatty acids, enteral intake), excesses of certain nutrients (calories, carbohydrates, lipids), types of lipid emulsions, and mineral toxicities (aluminum, copper, manganese) have been associated with PNALD. Strategies to address PNALD require correction of these risk factors. The use of newer mixed lipid emulsions (including soybean, medium-chain triglycerides, olive oil, and fish oil) may also have less hepatotoxicity than traditional soybean oil-based lipid emulsions.

Summary

Knowledge of nutritional risk factors for PNALD will help the clinician in the systematic evaluation and treatment of these specific risk factors. Moreover, an understanding of their effects guides the balance between addressing the patient’s nutritional needs and reducing the risk of PNALD.
Title
Nutritional Risk Factors in the Pathogenesis of Parenteral Nutrition-Associated Liver Disease
Authors
Berkeley N. Limketkai
Monica Choe
Shruti Patel
Neha D. Shah
Valentina Medici
Publication date
01-09-2017
Publisher
Springer US
Published in
Current Nutrition Reports / Issue 3/2017
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-017-0217-7
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 3/2017

Protein Intake in Chronic Kidney Disease

  • Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

The Challenges of Nutritional Assessment in Cirrhosis

  • Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Corporate Leanwashing and Consumer Beliefs About Obesity

  • Cardiovascular Disease (JHY Wu, Section Editor)

Nutrition at the End of Life: It’s Not What You Say, It’s How You Say It

  • Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Nutrition Therapy in End-Stage Lung Disease

  • Gastroenterology, Critical Care, and Lifestyle Medicine (SA McClave, Section Editor)

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images